Listing prospectus for Terveystalo’s EUR 100 million sustainability-linked notes available and listing application submitted

Terveystalo Plc Stock Exchange Release 1 June 2023 at 11.50 a.m EEST

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Terveystalo Plc (“Terveystalo”) announced on 25 May 2023 the issuance of senior unsecured sustainability-linked notes in the aggregate principal amount of EUR 100 million (the “Notes”). The Notes will mature on 1 June 2028 and carry initially a fixed annual interest of 5.375 per cent.

The Finnish Financial Supervisory Authority has today on 1 June 2023 approved the listing prospectus of the Notes. The listing prospectus is available in English on Terveystalo’s website at https://www.terveystalo.com/en/company/investors/.

Terveystalo has today filed an application with Nasdaq Helsinki Ltd ("Nasdaq Helsinki") for the admission to trading of the Notes on the official list of Nasdaq Helsinki.

Subject to the approval of the listing application, Nasdaq Helsinki is expected to admit the Notes to trading on the official list of Nasdaq Helsinki on or about 5 June 2023. The ISIN code of the Notes is FI4000523493.

The net proceeds of the issue of the Notes will be used for refinancing of the existing indebtedness of Terveystalo or its subsidiaries and for general corporate purposes of the Terveystalo group.

OP Corporate Bank plc and Skandinaviska Enskilda Banken AB (publ) acted as joint lead managers for the issue of the Notes and joint sustainability-linked framework advisers.

For further information, please contact:

Juuso Pajunen, CFO
Tel. +358 40 584 9722

Kati Kaksonen, Vice President, Investor Relations, Sustainability & Communications
Tel. +358 10 345 2034

Distribution:

Nasdaq Helsinki Ltd
Principal media
www.terveystalo.com

Important information

The information contained herein is not for release, publication or distribution, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, Singapore, South Africa or such other countries or otherwise in such circumstances in which the release, publication or distribution would be unlawful. The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any such jurisdiction. No actions have been taken to register or qualify the Notes, or otherwise to permit a public offering of the Notes.

This communication does not constitute an offer of securities for sale in the United States. The Notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) or the securities laws of any state of the United States, and the Notes may not be offered, sold, pledged or otherwise transferred, directly or indirectly, within the United States or to, or for the account or benefit of, any U.S. person (as such terms are defined in Regulation S under the Securities Act) except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.

This communication does not constitute an offer of Notes to the public in the United Kingdom. No prospectus has been or will be approved in the United Kingdom in respect of the Notes. Consequently, this communication is addressed to and directed only at persons in the United Kingdom who (i) have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”), (ii) are persons who are high net worth entities falling within Article 49(2)(a) to (d) of the Order, or (iii) are other persons to whom the Prospectus and offering of the Notes may be otherwise lawfully communicated (all such persons together being referred to as “relevant persons”). This release is directed only at relevant persons and any person who is not a relevant person must not act or rely on this release or any of its contents.

Terveystalo in brief

Terveystalo is the largest private healthcare service provider in Finland in terms of revenue and network. Terveystalo is also a leading occupational health provider in the Nordic region. We offer a wide variety of primary health care, specialized care, and well-being services for corporate and private customers and the public sector. Terveystalo’s s digital services are available 24/7, regardless of time and place. Health and well-being services are also provided by over 370 clinics across Finland. In Sweden, we offer occupational health services at 155 clinics. Terveystalo is listed on the Helsinki Stock Exchange.

In 2022, Terveystalo had approximately 1.3 million individual customers in Finland and the number of customer appointments was approximately 8.5 million, with more than a quarter of these being conducted via remote channels. Terveystalo employs over 16,800 healthcare and well-being professionals. www.terveystalo.com
 

Tags: